Atea Pharmaceuticals annual operating margin
2020
2021
Atea Pharmaceuticals's operating margin was 39.38% for fiscal 2021.
View full Atea Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | 39.38% | +62.06 pp |
| 2020 | 2020-12-31 | −22.68% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2021 | 2021-12-31 | 63.06% | — |
| Q3 2021 | 2021-09-30 | −67.50% | — |
| Q2 2021 | 2021-06-30 | 14.38% | — |
| Q1 2021 | 2021-03-31 | 46.46% | — |
Across the available reported history, Atea Pharmaceuticals's operating margin increased from −22.68% to 39.38%, a change of +62.06 percentage points. The latest reported quarter, Q4 2021, shows 63.06%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atea Pharmaceuticals filings at SEC.gov ↗